|Founder||Amy Baxter, M.D.|
Health & Wellness, Fitness, Tech
|Press Contact||Jennifer Tipping|
Pain Care Labs (a dba of MMJ Labs) was established in 2006 by pediatric emergency physician and pain researcher Amy Baxter. Her NIH funding led to the discovery of widespread needle fear, the critical components of pain, and an entire new platform for natural effective pain relief. Now she and her amazing team are out to change the world and eliminate unnecessary pain. The frequency Dr. Baxter used to create Buzzy® is now proven to inhibit pain better than TENS, improve muscle soreness, blood flow, recovery and more. With multiple patents and FDA 510(k) clearances to control and treat pain, the company created the VibraCool®. VibraCool’s M-Stim® pain relief was 2-3.4 times superior to electrical stimulation (TENS) for physical therapy; another demonstrated 35% fewer opioid tablets after knee surgery.
Distressed by other doctors’ indifference to needle pain, Dr. Baxter decided to help moms get their children vaccinated pain-free. Her prototype was so effective, she decided to “take a year or two” to study and develop the technology formally. When a colleague used her Buzzy device to avoid opioids for a knee replacement, she decided to quit practice in 2016 to invent and research full time. She is currently NIH NIDA funded to adapt her technology to reduce opioid use for low back pain – everything else was too easy! Now she and her amazing team are out to change the world and eliminate unnecessary pain.
Dr. Baxter directs innovation, invention, operations, and strategy for Pain Care Labs. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician Dr. Baxter founded PEMA Emergency Research while also founding Pain Care Labs (initially called MMJ Labs). Her contributions to science include creating and validating a pediatric pictorial nausea scale for nausea research, creating a liver enzyme algorithm to time abusive abdominal injury, creating the M-Stim platform for external pain relief, and extensive NIH scientific review group work. Accomplishments include pain and sedation textbook chapters, publications, national and international invited lectures, and testimony before HHS on the impact of needle fear on vaccination adherence; innovation impact comes from multiple NIH SBIR Fast-Tracks and patents developing Buzzy, VibraCool, and Duotherm pain relief and opioid-sparing devices.